ReviewBiomedicines2021

Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis.

Julio Plaza-Díaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.